Ginkgolide B reduces atherogenesis and vascular inflammation in ApoE-/- Mice

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Liu, Xiyun ^a   Zhao, Gexin ^a   Yan, Yan ^a   Bao, Li ^a   Chen, Beidong ^a   Qi, Ruomei ^a  

^a Ministry of Health   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APOLIPOPROTEIN E; CD40 LIGAND; GINKGOLIDE B; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RANTES; THROMBOCYTE FACTOR 4; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEINASE INHIBITION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; VASCULITIS;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PLATELETS; CD40 LIGAND; CHEMOKINE CCL5; GINKGOLIDES; HUMANS; LACTONES; LIPIDS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P-SELECTIN; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PLAQUE, ATHEROSCLEROTIC; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET FACTOR 4; PROTO-ONCOGENE PROTEINS C-AKT; VASCULAR CELL ADHESION MOLECULE-1; VASCULITIS;

MUS;

EID: 84861006695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036237     Document Type: Article

References (29)

1. King SM, McNamee RA, Houng AK, Patel R, Brands M, et al. (2009) Platelet dense-granule secretion plays a critical role in thrombosis and subsequent vascular remodeling in atherosclerotic mice. Circulation 120: 785-791.
2. Massberg S, Brand K, Grüner S, Page S, Müller E, et al. (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196: 887-896.
3. Coppinger JA, Maguire PB, (2007) Insights into the platelet releasate. Curr Pharm Des 13: 2640-2646.
4. Zucker, MB, Katz IR, (1991) Platelet factor 4: production, structure, and physiologic and immunologic action. Proc Soc Exp Biol Med 198: 693-702.
5. Nassar T, Sachais BS, Akkawi S, Kowalska MA, Bdeir K, et al. (2003) Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 278: 6187-6193.
6. Kasper B, Brandt E, Bulfone-Paus S, Petersen F, (2004) Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood 103: 1602-1610.
7. Nassar T, Sachais BS, Akkawi S, Kowalska MA, Bdeir K, et al. (2003) Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 278: 6187-6193.
8. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, et al. (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9: 61-67.
9. Westmuckett AD, Thacker KM, Moore KL, (2011) Tyrosine sulfation of native mouse Psgl-1 is required for optimal leukocyte rolling on P-selectin in vivo. PLoS One 6 (5): e20406.
10. Schober A, Manka D, von Hundelshausen P, Huo Y, Hanrath P, et al. (2002) Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 106: 1523-1529.
11. Lamant V, Mauco G, Braquet P, Chap H, Douste-Blazy L, (1987) Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Glinkgo biloba. Biochem Pharmacol 36: 2749-2852.
12. Braquet P, (1986) Proof of involvement of PAF-acether in various immune disorders using BN52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo billoba L. Adv Prostaglandin Thromboxane Leukot Res 16: 179-198.
13. Zhan S, Chen B, Wu W, Li B, Qi R, (2011) Ginkgolide B reduces inflammatory protein expression in oxidized low-density lipoprotein-stimulated human vascular endothelial cells. J Cardiovasc Pharmcol 57: 721-727.
14. Li R, Chen B, Wu W, Li J, Qi R, (2009) Ginkgolide B suppresses intercellular adhesion molecule-1 expression via blocking nuclear factor-κB activation in human vascular endothelial cells stimulated by oxidized low-density lipoprotein. J Pharmacol Sci 110: 362-369.
15. McClelland S, Gawaz M, Kennerknecht E, Konrad CS, Sauer S, et al. (2009) Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse. Atherosclerosis 202: 84-91.
16. Cyrus T, Sung S, Zhao L, Funk CD, Tang S, et al. (2002) Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation 106: 1282-1287.
17. Voss B, McLaughlin JN, Holinstat M, Zent R, Hamm HE, (2007) PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis. Mol Pharmacol 71: 1399-1406.
18. Chen J, Damron DS, Chen WS, Hay N, Byzova TV, (2004) Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 104: 1703-1710.
19. Rex S, Beaulieu LM, Perlman DH, Vitseva O, Blair PS, et al. (2009) Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and α-granule release. Thromb Haemost 102: 97-110.
20. Penna C, Alloatti G, Cappello S, Gattullo D, Berta G, et al. (2005) Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. Am J Physiol Heart Circ Physiol 288: H2512-H2520.
21. Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Vitoratos N, et al. (2007) Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene. Atherosclerosis 193: 142-150.
22. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, et al. (2004) Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 94: 253-261.
23. Santilli F, Basili S, Ferroni P, Davì G, (2007) CD40/CD40L system and vascular disease. Intern Emerg Med 2: 256-268.
24. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C, (2009) The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 54: 669-677.
25. Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, et al. (2007) CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 115: 1571-1580.
26. Scheuerer B, Ernst M, Dürrbaum-Landmann I, Fleischer J, Grage-Griebenow E, et al. (2000) The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 95: 1158-1166.
27. Kisucka J, Chauhan AK, Zhao BQ, Patten IS, Yesilaltay A, et al. (2009) Elevated levels of soluble P-selectin in mice alter blood-brain barrier function, exacerbate stroke, and promote atherosclerosis. Blood 113: 6015-6022.
28. Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, et al. (1999) Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 84: 1237-1244.
29. Johnson RC, Chapman SM, Dong ZM, Ordovas JM, Mayadas TN, et al. (1997) Absence of P-selectin delays fatty streak formation in mice. Clin Invest 99: 1037-1043.